1. Sabbobeh, R., H. Hejaz, A. Jahajha, S. Al-Akhras, H. Al-Jaas and S. Abu-Lafi, 2016. Antioxidant an antimicrobial activities of the leaf extract of Salvia palaestina. J. Applied Pharm. Sci., 6: 76-82.
   Direct Link  |  
2. Sabbobeh, R., H. Hejaz, H. Al-Jaas, A. Jahajha and S. Abu-Lafi, 2015. Phytochemical analysis of cultivated and wild salvia Palaestina using GC-MS: A comparative study. World J. Pharm. Sci., 3: 2348-2356.
   Direct Link  |  
3. Hejaz, H., R. Sabbobeh, H. Al-Jaas, A. Jahajha and S. Abu-Lafi, 2015. Essential oil secondary metabolites variation of Salvia palaestina leaves growing wild from different locations in Palestine. J. Applied Pharm. Sci., 5: 84-89.
   Direct Link  |  
4. Hejaz, H. and R. Karaman, 2015. Drugs Overview. In: Common Used Drugs-Uses, Side Effects, Bioavailability and Approaches to Improve It, Karaman, R. (Ed.)., Nova Science Publishers, New York, USA., pp: 1-40.
5. Khdour, M.R., H.O. Hallak, H. Hejaz, M. Shaeen and M. Dweib, 2014. Patterns of NSAIDs use in Palestinian mid-territories: A prospective study of ambulatory patients in outpatient pharmacies. Current Clin. Pharmacol., 9: 10-16.
   PubMed  |  Direct Link  |  
6. Hejaz, H., R. Karaman and M. Khamis, 2012. Computer-assisted design for paracetamol masking bitter taste prodrugs. J. Mol. Model., 18: 103-114.
   CrossRef  |  PubMed  |  Direct Link  |  
7. Leese, M.P., H.A. Hejaz, M.F. Mahon, S.P. Newman, A. Purohit, M.J. Reed and B.V. Potter, 2005. A-ring-substituted estrogen-3-O-sulfamates: Potent multitargeted anticancer agents. J. Med. Chem., 48: 5243-5256.
   CrossRef  |  PubMed  |  Direct Link  |  
8. Hejaz, H.A., L.L. Woo, A. Purohit, M.J. Reed and B.V. Potter, 2004. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase. Bioorg. Med. Chem., 12: 2759-2772.
   CrossRef  |  PubMed  |  Direct Link  |  
9. Purohit, A., L.W.L. Woo, D. Barrow, H.A.M. Hejaz, R.I. Nicholson, B.V.L. Potter and M.J. Reed, 2001. Non-steroidal and steroidal sulfamates: New drugs for cancer therapy. Mol. Cell. Endocrinol., 171: 129-135.
   CrossRef  |  PubMed  |  Direct Link  |  
10. Singh, A., A. Purohit, H.A.M. Hejaz, B.V.L. Potter and M.J. Reed, 2000. Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate. Mol. Cell. Endocrinol., 160: 61-66.
    CrossRef  |  Direct Link  |  
11. Purohit, A., H.A.M. Hejaz, A. Singh, L. Walden and L. MacCarthy-Morrogh et al., 2000. 2-Methoxyestrone-3-O-sulfamate: A novel drug for cancer therapy. Int. J. Cancer, 85: 584-589.
12. MacCarthy-Morrogh, L., P.A. Townsend, A. Purohit, H.A. Hejaz, B.V. Potter, M.J. Reed and G. Packham, 2000. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells. Cancer Res., 60: 5441-5450.
    PubMed  |  Direct Link  |  
13. Purohit, A., H.A.M. Hejaz, L.W.L. Woo, A.E. Van Strien, B.V.L. Potter and M.J. Reed, 1999. Recent advances in the development of steroid sulphatase inhibitors. J. Steroid Biochem. Mol. Biol., 69: 227-238.
    CrossRef  |  Direct Link  |  
14. Hejaz, H.A., A. Purohit, M.F. Mahon, M.J. Reed and B.V. Potter, 1999. Synthesis and biological activity of the superestrogen (E)-17-Oximino-3-O-sulfamoyl-1, 3, 5 (10)-estratriene: X-ray crystal structure of (E)-17-Oximino-3-hydroxy-1, 3, 5 (10)-estratriene. J. Med. Chem., 42: 3188-3192.
    CrossRef  |  Direct Link  |  
15. Woo, L.L., N.M. Howarth, A. Purohit, H.A. Hejaz, M.J. Reed and B.V. Potter, 1998. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. J. Med. Chem., 41: 1068-1083.
    CrossRef  |  Direct Link  |  
16. Purohit, A., K.A. Vernon, A.W. Hummelinck, L.W.L. Woo, H.A.M. Hejaz, B.V.L. Potter and M.J. Reed, 1998. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. J. Steroid Biochem. Mol. Biol., 64: 269-275.
    CrossRef  |  Direct Link  |